A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers

Clinical trial NCT06204250 · COMPLETED

Trial details

NCT number: NCT06204250
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vasomotor Symptoms Adult Healthy Volunteers

Start date: 2024-02-27
Primary completion: 2024-12-19
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.